A new liver disease awareness video from Madrigal Pharmaceuticals follows a patient advocate spreading the word to take NASH seriously. (Number One Liver Fan via YouTube)

November 10, 2023 09:24 AM EST

Marketing

Madrigal builds on liver disease awareness campaigns as it awaits FDA decision on NASH drug resmetirom

Beth Snyder Bulik

Senior Editor

Madrigal Pharmaceuticals wants people with fatty liver disease to be the number one fan of their livers. Its new “patient service announcement,” shown first on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Madrigal builds on liver disease awareness campaigns as it awaits FDA decision on NASH drug resmetirom

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Madri­gal builds on liv­er dis­ease aware­ness cam­paigns as it awaits FDA de­ci­sion on NASH drug resme­tirom

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Madrigal builds on liver disease awareness campaigns as it awaits FDA decision on NASH drug resmetirom